Application 079121
- Type
- ANDA
- Sponsor
- TARO
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ESCITALOPRAM OXALATE | ESCITALOPRAM OXALATE | SOLUTION;ORAL | EQ 5MG BASE/5ML | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 51672-1348 | Escitalopram | Escitalopram Oxalate | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-1348 | Escitalopram | Escitalopram Oxalate | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |
| 51672-1348 | Escitalopram | Escitalopram Oxalate | Taro Pharmaceuticals U.S.A., Inc. | ANDA | Current |